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Acute respiratory distress syndrome (ARDS) causes significant morbid-
ity and mortality. Exacerbating factors increasing the risk of ARDS
remain unknown. Supplemental oxygen is often necessary in bothmild
and severe lung disease. The potential effects of supplemental oxygen
may include augmentation of lung inflammation by inhibiting anti-
inflammatory pathways in alveolar macrophages. We sought to deter-
mineoxygen-derivedeffectsontheanti-inflammatoryA2Aadenosinergic
(ADORA2A) receptor inmacrophages, and the role of the ADORA2A
receptor in lung injury. Wild-type (WT) and ADORA2A2/2 mice re-
ceived intratracheal lipopolysaccharide (IT LPS), followed 12 hours
later by continuous exposure to 21% oxygen (control mice) or 60%
oxygenfor1 to3days.Wemeasuredthephenotypicendpointsof lung
injury and the alveolarmacrophage inflammatory state.We tested an
ADORA2A-specific agonist, CGS-21680 hydrochloride, in LPS plus
oxygen-exposed WT and ADORA2A2/2 mice. We determined the
specific effects of myeloid ADORA2A, using chimera experiments.
Compared withWTmice, ADORA2A2/2 mice exposed to IT LPS and
60%oxygendemonstrated significantlymore histologic lung injury,
alveolar neutrophils, and protein. Macrophages from ADORA2A2/2
miceexposedtoLPSplusoxygenexpressedhigher concentrationsof
proinflammatory cytokines and cosignaling molecules. CGS-
21680 prevented the oxygen-induced augmentation of lung injury
after LPS only inWTmice. Chimera experiments demonstrated that
the transfer of WT but not ADORA2A2/2 bone marrow cells into
irradiated ADORA2A2/2 mice reduced lung injury after LPS plus ox-
ygen, demonstrating myeloid ADORA2A protection. ADORA2A is
protective against lung injury after LPS and oxygen. Oxygen after
LPS increases macrophage activation to augment lung injury by
inhibiting the ADORA2A pathway.
Keywords: acute lung injury; oxygen; A2A adenosinergic receptor;
lung injury resolution; ARDS modifiable risk factors
Acute lung injury (ALI) and its more severe form, acute respira-
tory distress syndrome (ARDS), have an annual incidence of more
than 195,000 cases. Despite 35–40%mortality even in tertiary-care
center intensive care units, few interventions improve survival (1).
Because pulmonary inflammation precedes the onset of clinically
defined ARDS, the identification of factors that can accelerate or
augment inflammation in the pathogenesis of ARDS could lead to
new therapeutic approaches to limit disease incidence and reduce
mortality. Patients frequently develop ALI after admission to the
hospital (2–5), implying a possibility that potentially modifiable
in-hospital exposures could contribute to the development of ALI
in predisposed hosts. Supplemental oxygen (40–60%) comprises
one such exposure (4–6).
We have shown that the delivery of supplemental oxygen
(60%) 12 hours after a direct instillation of low-dose intratra-
cheal lipopolysaccharide (IT LPS) augments murine lung injury
(7). Alveolar macrophages exposed to LPS plus 60% oxygen
exhibited a proinflammatory phenotype, with an increased ex-
pression of cosignaling molecules and reactive oxygen species
(ROS) and an increased secretion of proinflammatory cyto-
kines, including neutrophil-recruiting chemokines. We and
others have demonstrated the importance of neutrophil alveo-
litis in experimental models of lung injury (7–9), but factors
conducive to a macrophage inflammatory state and that state’s
direct influence on the influx of neutrophils also comprise an
important, yet understudied, area (10). Because of their ubiq-
uitous tissue distribution, macrophages can generate a prompt,
robust inflammatory response to a variety of stimuli. However,
when inflammation is unregulated, excessive alveolar neutrophil
accumulation and lung injury may occur (11–14).
Alveolar macrophages are activated by the engagement of
pattern-recognition receptors (15, 16). Classically activated M1-
type alveolar macrophages are an important component of the
initial innate immune response, and they secrete the proinflam-
matory cytokines TNF-a and macrophage inflammatory protein
2 (MIP-2) to augment that response. They also express CD86 and
CD40, costimulatory molecules capable of regulating inflamma-
tion in innate immunity via communication with lymphocytes or
neutrophils (17, 18). Janssen and colleagues demonstrated that
resident alveolar macrophages demonstrate plasticity through
a cycle of inflammation and resolution (10) in a lung injury
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CLINICAL RELEVANCE
Exacerbating factors leading to acute lung injury remain
incompletely known. Supplemental oxygen may augment
macrophage inflammation by inhibiting anti-inflammatory
pathways. Moderate concentrations of supplemental oxygen
block the tissue-protective, anti-inflammatory A2A adenosi-
nergic (ADORA2A) receptor in macrophages, to augment
their proinflammatory state. ADORA2A-deficient macro-
phages significantly contribute to augmentations of lung injury
in an experimental model.
 
model, first manifesting a proinflammatory phenotype critical to
the propagation of lung inflammation, but subsequently develop-
ing an anti-inflammatory profile crucial for resolution (10, 13, 14,
19, 20). The macrophage response must be tightly controlled,
because an excess release of M1-type mediators can lead to
host-tissue damage (21, 22). Therefore, the induction of anti-
inflammatory macrophage pathways likely occurs soon after the
initial inflammatory burst, as a necessary mechanism to counter-
act and regulate inflammation.
Adenosine released by cells in response to local hypoxia and in-
flammation binds to adenosine receptors (8, 23–25). The activation
of adenosinergic receptors, particularly A2A (ADORA2A) and
A2B (ADORA2B), can modulate inflammation and promote
tissue protection (8, 25). ADORA2A is one of four G-protein–
coupled receptors widely expressed in leukocytes and nonhe-
matopoietic cells, and has the highest affinity for adenosine
binding (23–25). Adenosine binding to its receptor increases
cyclic adenosine monophosphate (cAMP), leading to an in-
crease in protein kinase A, which inhibits NF-kB through its
scaffold A kinase-anchoring protein 95 (26, 27). Previous work
in lung-injury models focused on the protective role of neutrophil
ADORA2A (8, 24, 25, 28). Thiel and colleagues demonstrated that
supplemental oxygen blunts the hypoxia-induced up-regulation of
neutrophil ADORA2A to propagate inflammation (8), but the role
of macrophage ADORA2A in modulation of lung injury has not
been investigated.
We sought to identify alveolar macrophage–associated mecha-
nisms that regulate the intensity and duration of inflammation. We
have shown that supplemental oxygen augments the macrophage
M1, proinflammatory state present in LPS-stimulated macrophages.
We also know that regulation of the macrophage inflammatory state
is critical to controlling tissue inflammation. Because ADORA2A
can prevent excessive tissue inflammation, we examine the effects of
macrophage ADORA2A in regulating the oxygen-induced aug-
mentation of the macrophage inflammatory state and subsequent
lung injury. In this study, we demonstrate that macrophage
ADORA2A modulates the oxygen-induced augmentation of
lung injury after LPS. Exposure to continuous supplemental
oxygen decreased LPS-mediated macrophage ADORA2A activa-
tion to promote a proinflammatory M1 phenotype, and to augment
lung injury. Mice deficient in ADORA2A demonstrate an exagger-
ated oxygen-mediated effect, further demonstrating the importance
of ADORA2A in regulating the macrophage inflammatory state.
MATERIALS AND METHODS
Animals
Male C57BL/6 wild-type (WT), ADORA2A2/2, and B6.SJL-Ptprca
Pep3b/BoyJ (CD45.1) male mice (aged 8–10 wk) were purchased from
Jackson Laboratories (Bar Harbor, ME) and housed at the Asthma
and Allergy Center of Johns Hopkins University. Experiments were
performed according to a protocol approved by the Animal Care and
Use Committee of Johns Hopkins University.
Animal Injection and Processing
We anesthetized and injected mice as previously described (7, 17). We
used Escherichia coli LPS (O55:B5, catalogue number L2880; Sigma
Chemical Company, St. Louis, MO) at 0.3 mg/g mouse or sterile water
(vehicle control). We processed mice on Days 1 to 3 after LPS expo-
sure, as described elsewhere (7, 17) and in the online supplement.
Oxygen Exposure
Twelve hours after exposure to IT LPS or water, mice were placed in
customized, sealed cages with food and water ad libitum, and continu-
ous 60% oxygen was delivered as described elsewhere (7) and in the
online supplement.
Systemic Delivery of Products (Anti–Myeloid Differentiation
Antigen–1 Antibody and CGS-21680)
Neutrophil depletion was performed as previously described (7). WT
and ADORA2A2/2 animals received 125 mg/dose/mouse of intraperito-
neally injected CGS-21680 hydrochloride (Tocris Bioscience, Bristol, UK)
or DMSO at 12 hours (concurrent with the initiation of oxygen exposure),
36 hours, and 60 hours after IT LPS.
Analysis of Bronchoalveolar Lavage
Bronchoalveolar lavage (BAL) was obtained, total and differential cells
were counted, and BAL protein was assessed as described elsewhere (7)
and in the online supplement. TNF-a, keratinocyte-derived chemokine
(KC), MIP-2, IL-17, and LPS-induced chemokine (LIX) were mea-
sured in BAL and the culture medium by ELISA. ROS were measured
as described in the online supplement.
Histology and Lung-Injury Scoring
Lungs were processed and assessed for histologic evaluation and scor-
ing, as described elsewhere (7) and in the online supplement.
Macrophage Isolation and Culture
Alveolar or peritoneal macrophages or transformed murine alveolar
macrophages (MH-S) cells (CRL-2019; American Type Culture Collec-
tion, Manassas, VA) were exposed to LPS (100 ng/ml) and/or 60% ox-
ygen, as described elsewhere (1) and in the online supplement. NF-kB
cell-permeable inhibitor synthetic peptide (SN-50) (P-600, 50 mg/ml;
Enzo, Farmingdale, NY) or control (P-601; Enzo), ADORA2A agonist
CGS-21680 (5 mM; Tocris Bioscience), nonselective adenosine receptor
agonist (NECA, 3 mM; Tocris Bioscience), or dimethyloxallyl glycine (sham)
were used.
Intracellular cAMP and NF-kB Activity
We assessed intracellular cAMP according to the cAMP enzyme immu-
noassay protocol (RPN225; GE Healthcare, Piscataway, NJ), and NF-kB
activity according to the Active Motif protocol (p65, 40096; Active Motif,
Carlsbad, CA).
Quantitative RT-PCR
Total RNA was isolated and processed for RT-PCR using ADORA2A
and ADORA2B primers, as described elsewhere (26, 29) and in the
online supplement.
Bone Marrow Isolation, Adoptive Transfer, and Chimeras
We harvested bone marrow (BM) cells from ADORA2A2/2 and CD45.1
mice, and recipient mice (5–6 wk) were irradiated and housed as described
elsewhere (17) and in the online supplement. Two hours after irradiation,
we injected 1.5 3 106 BM cells intravenously (17).
Flow Cytometry
Cells were processed for flow cytometry and analyzed as described else-
where (7) and in the online supplement, using the antibodies (or relevant
isotypes) anti–annexin V–PE, anti–7-AAD, anti–LY6G-FITC, anti–IA-
IE-PE, anti–CD11b-APCe780, anti–CD45.1-PE, anti–CD45.2-PerCy5.5,
anti–CD14-FITC, anti–CD86-APC, anti–CD80-PE, and anti-F4/80-APC.
Statistical Analysis
All values are reported as means 6 SEMs. Markers of injury were
compared using the Student t test or Mann-Whitney rank sum test.
Multiple groups were compared using one-way ANOVA or one-way
ANOVA on ranks. Pairwise comparisons were performed using the
Student t test with Bonferroni correction. Statistical analysis was per-
formed using Sigmaplot version 11.0 (Systat Software, Chicago, IL).
The survival curve was established with Kaplan-Meier survival analysis.
P , 0.05 was considered significant.
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RESULTS
The Absence of ADORA2A Augments Early Lung Injury after
LPS and 60% Oxygen
WT and ADORA2A2/2 mice were exposed to IT LPS (0.3 mg/kg/
mouse) or water, followed 12 hours later by exposure to supple-
mental oxygen (60%) or room air, which was continued until the
mice were killed. The time was defined by days after IT LPS or IT
water. Lung injury at early time points was significantly increased
in LPS plus oxygen-exposed ADORA2A2/2 mice, compared with
similarly treated WT mice and all other treatment groups (Figure
1). In this group, we observed a significant increase in histologic
damage (Figure 1A), BAL protein (Figure 1B), and BAL neutro-
phils (Figure 1C), compared with all other groups. Differences
appeared on Day 2, and persisted on Day 3 for BAL protein
and histologic injury after LPS instillation. BAL macrophage num-
bers appeared to increase in all groups on Day 3, but with no
differences between those groups (Figure 1E). The addition of
60% oxygen to IT water did not significantly increase the mea-
sured lung injury parameters in WT or ADORA2A2/2 mice. On
Figure 1. Anti-inflammatory A2A
adenosinergic receptor–deficient
(ADORA2A2/2) mice exposed to
LPS plus oxygen demonstrated
a significant increase in lung injury
compared with ADORA2A2/2
mice exposed to LPS alone, and
compared with wild-type (WT)
mice exposed to LPS plus oxygen.
Statistics were performed by com-
paring all groups at the same time
point. (A) Histology. Representa-
tive low-power (34) and high-
power (inset, 340) hematoxylin
and eosin–stained lung sections
on Days 2 and 3 reveal increased
alveolar consolidation and intersti-
tial infiltration in ADORA2A2/2
mice exposed to LPS plus oxygen.
Quantitative assessment using
a lung-injury scoring system dem-
onstrated a significant increase in
lung injury in ADORA2A2/2 mice
exposed to LPS plus oxygen, be-
ginning on Day 2 and persisting
until Day 3. *On Day 2, significant
compared with the WT water
(W) 1 O2 group. ^On Day 2, sig-
nificant compared with all other
groups. ^On Day 3, significant
compared with the WT LPS (L) 1
O2 group. (B) Bronchoalveolar la-
vage (BAL) protein was notable
for an early, pronounced increase
in ADORA2A2/2 mice exposed to
LPS plus oxygen. *On Day 1, sig-
nificant compared with the WT W
and ADORA2A2/2 W groups. *On
Day 2, significant compared with
the WT W1 O2 and ADORA2A
2/2
W 1 O2 groups. ^On Day 2, sig-
nificant compared with the WT LPS,
WT L 1 O2, and ADORA2A
2/2 LPS
groups. ^On Day 3, significant
compared with the WT LPS, WT
L 1 O2, and ADORA2A
2/2 LPS
groups. (C) The BAL total cell count
was increased in ADORA2A2/2
mice exposed to LPS plus oxygen,
compared with all other exposure groups on Day 2. *On Day 1, significant compared with the WT W and ADORA2A2/2 W groups. *On Day 2,
significant compared with the WT W 1 O2 and ADORA2A
2/2 W 1 O2 groups. ^On Day 2, significant compared with the WT LPS, WT L 1 O2, and
ADORA2A2/2 LPS groups. ^On Day 3, significant compared with the WT LPS and ADORA2A2/2 LPS groups. (D) BAL Neutrophils were also increased
in ADORA2A2/2 mice exposed to LPS plus oxygen on Day 2. *On Day 1, significant compared with the WT W and ADORA2A2/2 W groups. *On Day
2, significant compared with the WT W1 O2 and ADORA2A
2/2 W1 O2 groups. ^On Day 2, significant compared with the WT LPS, WT L1O2, and
ADORA2A2/2 LPS groups. ^On Day 3, significant compared with the WT LPS and ADORA2A2/2 LPS groups. (E) BAL macrophages did not increase
in ADORA2A2/2 mice exposed to LPS plus oxygen, compared with all other groups at each time point (n ¼ 4 in the W and W 1 O2 groups; n ¼ 6–8
in the LPS and L 1 O2 groups). n.s., no significance.
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Days 1 and 2, lung water accumulation was no different in WT and
ADORA2A2/2 mice. We previously observed an oxygen-induced
augmentation of lung water content no earlier than Day 4 (7).
ADORA2A2/2 mice demonstrated a significant increase in both
lung injury and mortality when treated with higher doses of LPS
(1–3 mg/kg/mouse; no supplemental oxygen) (Figure E1A in the
online supplement), but not at the primary study dose (0.3 mg/kg/
mouse). When we depleted neutrophils in ADORA2A2/2 mice
exposed to LPS plus oxygen, lung injury was significantly abro-
gated (Figure E1B), and the expression of alveolar macrophage
CD86 was reduced (Figure E1C).
ADORA2A-Deficient Alveolar Macrophages Are
Proinflammatory after LPS and Oxygen
To begin assessing ADORA2A-mediated differences in alveolar
inflammation, we measured proinflammatory cytokines at early
time points (Figure 2). BAL TNF-a and MIP-2 were signifi-
cantly increased in ADORA2A2/2 mice exposed to LPS plus
oxygen compared with WT mice exposed to LPS plus oxygen,
and in comparison with other experimental groups on Day 1
(Figure 2A). MIP-2 is a potent neutrophil chemoattractant pri-
marily secreted by macrophages. In ADORA2A2/2 mice ex-
posed to LPS plus oxygen, increased BAL MIP-2 secretion
occurred before the increase in alveolar neutrophils observed
on Day 2. No difference in BAL MIP-2 or TNF-a was evident
between WT and ADORA2A2/2mice exposed to IT water plus
60% oxygen. Other neutrophil chemokines, including IL-17,
KC, and LIX, were not increased in ADORA2A2/2 mice ex-
posed to LPS plus oxygen; they are primarily secreted by other
cell-types, and not macrophages (Figure 2B).
We also assessed ADORA2A-mediated differences in neutro-
phil and macrophage life spans in the inflammatory milieu of the
alveolar space by measuring cell apoptosis, a process known to be
crucial in the modulation of inflammation (10, 19). Compared with
other groups, BAL neutrophils from ADORA2A2/2 mice ex-
posed to LPS plus oxygen exhibited similar apoptotic rates on
Days 2 or 3, as assessed by annexin V staining (Figure 2C). In
contrast, alveolar macrophages from ADORA2A2/2 mice ex-
posed to LPS plus oxygen produced significantly less activated
caspase-3, a marker of macrophage apoptosis (10), compared
with WT macrophages exposed to LPS plus oxygen (Figure 2D).
Figure 2. Macrophages from ADORA2A2/2 mice secrete
more neutrophil-recruiting chemokines and are less apo-
ptotic after exposure to LPS plus oxygen, compared with
WT mice. Statistics were determined by comparing all
groups at the same time point. (A) BAL concentrations of
macrophage inflammatory protein–2 (MIP-2) and TNF-a
were increased in ADORA2A2/2 mice exposed to LPS plus
oxygen on Day 1. ^Significant compared with the WT LPS,
WT L 1 O2, and ADORA2A
2/2 LPS groups. (B) Other che-
mokines, including keratinocyte-derived chemokine (KC),
IL-17, and LPS-induced chemokine (LIX), were not in-
creased in ADORA2A2/2 mice exposed to LPS plus oxy-
gen, compared with WT mice. ^Significant compared
with all other groups on BAL KC Day 1. *Significant com-
pared with the WT W 1 O2 group on BAL KC Day 1.
*Significant compared with the WT W 1 O2 group on
BAL KC Day 2. ^Significant compared with all other
groups on BAL KC Day 2. For BAL IL-17, no difference
was evident between the assessed groups. *For BAL LIX,
significant compared with theWT and ADORA2A2/2 W1O2
groups. (C) Amounts of annexin V, a marker of BAL neu-
trophil apoptosis, were no different between any of the
assessed groups on either Day 2 or Day 3. (D) Amounts
of activated caspase-3, a marker of BAL macrophage (F4-
801 CD11b1) apoptosis, were significantly lower in
ADORA2A2/2 mice exposed to LPS plus oxygen. ^Signifi-
cant difference compared with the WT LPS, WT L 1 O2,
and ADORA2A2/2 LPS groups, and with no difference be-
tween the WT LPS and ADORA2A2/2 LPS groups (n ¼ 4 in
theW andW1 O2 groups, and n¼ 6–8 in the LPS and L1O2
groups). Macs, macrophages.
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To assess the macrophage inflammatory state, we measured
the intracellular mean fluorescence intensity of proinflammatory
cytokines in CD11b1 alveolar macrophages (defined by high
forward–side scatter and F4-80 positivity; see Figure E2A and
Table 1). Others have demonstrated F4-80 to be a reliable al-
veolar macrophage marker, and CD11b to be a marker of
a recruited or exudative (in contrast to resident) macrophages
(10, 30, 31). We found that the percentage of F4-80 positivity
according to flow cytometry correlates with BAL macrophages
identified by cytospin and Diff-Quik staining (Figure 1E). The
exposure of WT or ADORA2A2/2 mice to LPS plus oxygen
increased the percentage of CD11b1 expression among F4-801
alveolar macrophages, compared with LPS plus room air mac-
rophages (Table 1). BAL macrophages (F4-801 CD11b1) from
ADORA2A2/2 mice exposed to LPS plus oxygen exhibited
more monocyte chemoattractant protein-1 (MCP-1) and TNF-a
than did WT mice exposed to LPS plus oxygen, or ADOR-
A2A2/2 mice exposed to LPS plus room air (Table 1 and Figure
3A; a representative histogram is presented in Figure E2B). Add-
ing 60% oxygen to LPS similarly increased alveolar macrophage
ROS production in WT and ADORA2A2/2 mice (Figure 3B).
In the alveolar microenvironment, macrophage communica-
tion with other cells, including alveolar epithelial cells, recruited
monocytes, or neutrophils, may influence the macrophage phe-
notype (18, 30). To examine specific macrophage effects, we
isolated alveolar macrophages (AMs) from unchallenged WT
or ADORA2A2/2 mice, and then exposed them to LPS, oxy-
gen, or a combination of both in culture for 12 to 24 hours. At
12 hours, LPS-exposed alveolar macrophages (AMs) from WT
and ADORA2A2/2 mice produced more TNF-a than did con-
trol WT AMs (Figure 3C). The addition of oxygen 3 hours after
LPS further increased TNF-a in AMs from ADORA2A2/2




Day 2 Exposure Percent F4-801 Percent CD11b1 MCP-1 MFI TNF-a MFI
WT LPS (L) 13 (1.4) 33 (5.2) 41 (12.7) 53 (2.6)
A2AR2/2 LPS 12 (2.8) 38 (6.3) 46 (3.1) 51 (3.9)
WT L 1 O2 10 (0.7)* 51 (1.7)* 63 (9.3) 68 (2.4)
A2AR2/2 L 1 O2 8 (3.6)* 51 (3.1)* 90 (2.4)
† 95 (2.9)†
Definition of abbreviations: ADORA2A, anti-inflammatory A2A adenosinergic
receptor; A2AR2/2, ADORA2A-deficient; BAL, bronchoalveolar lavage; L, lipo-
polysaccharide; MCP, monocyte chemoattractant protein; MFI, mean fluores-
cence intensity; WT, wild-type.
Day 2 BAL exudative macrophages (F4-801 CD11b1) from ADORA2A2/2 mice
exposed to LPS plus oxygen produced more TNF-a and MCP-1, as determined by
intracellular staining using flow cytometry. Statistics were determined by com-
paring all groups with one-way ANOVA. Values are listed as averages (SEMs) (n ¼
4–6 in each group).
* Significant compared with the WT LPS and ADORA2A2/2 LPS groups.
y Significant compared with theWT LPS, ADORA2A2/2 LPS, andWT L1 O2 groups.
Figure 3. ADORA2A-deficient macrophages
exposed to LPS plus oxygen demonstrate
increased cytokine production as well as
cosignaling molecule expression, com-
pared with WT macrophages. Statistics
were performed by comparing all groups
at the same time point. (A) MCP-1 and
TNF-a were increased in macrophages
(F4-801 CD11b1) from ADORA2A2/2
mice exposed to LPS plus oxygen. *Sig-
nificant compared with the WT LPS,
ADORA2A2/2 LPS, and WT L 1 O2
groups. MFI, mean fluorescence inten-
sity. (B) As a marker of reactive oxygen
species (ROS) production, the 29,79-
dichlorofluorescein (DCF) measured in al-
veolar macrophages was higher in both
WT and ADORA2A2/2 mice exposed to
LPS and oxygen. *Significant compared
with all other groups, with nonsignificant
differences between the WT L 1 O2 and
ADORA2A2/2 L 1 O2 groups. (C) Using
alveolar macrophages (Alv Macs.) isolated
from unchallenged WT or ADORA2A2/2
mice and exposed in culture to LPS,
60% oxygen, or the two in combination,
we observed the most significant increase
in TNF-a and CD86 in macrophages from
ADORA2A2/2 mice exposed to LPS and ox-
ygen after 12 hours. *For intracellular
(IC) TNF-a, significant compared with
WT media (M). ^For IC TNF-a, significant
compared with the WT LPS, WT L 1 O2,
and ADORA2A2/2 LPS groups, with no dif-
ference between the ADORA2A2/2 LPS,
WT LPS, or WT L 1 O2 groups. ^For
CD86, significant compared with the
WT LPS, WT L 1 O2, and ADORA2A
2/2
LPS groups. (D) When assessed after 24 hours of exposure, macrophages from ADORA2A2/2 mice exposed to LPS plus oxygen secreted more TNF-a
and MIP-2. *Significant compared with WT media. ^Significant compared with the WT LPS, WT L 1 O2, and ADORA2A
2/2 LPS groups (n ¼ 5–6 in
each group).
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mice, but not in AMs from WT mice. Cosignaling molecule
CD86 expression at 12 hours after LPS plus oxygen was in-
creased only in AMs from ADORA2A2/2 mice (Figure 3C).
Supplemental oxygen did not increase TNF-a or CD86 in
media-exposed macrophages from WT or ADORA2A2/2 mice.
Exposing AMs from WT or ADORA2A2/2 mice to LPS for
24 hours significantly increased both TNF-a and MIP-2, com-
pared with media exposure. Adding oxygen to LPS further
increased TNF-a and MIP-2 only in AMs from ADORA2A2/2
mice (Figure 3D).
Oxygen Suppresses LPS-Induced Augmentation of ADORA2A
to Promote Inflammation and Lung Injury
In ADORA2A2/2 mice, LPS plus oxygen augments lung injury
and the M1 macrophage proinflammatory state. Therefore, we
wanted to determine whether ADORA2A manipulation in WT
mice might alter lung inflammation. CGS-21680 is a specific
ADORA2A agonist that increases ADORA2A pathway activ-
ity (32). A daily systemic delivery of CGS-21680 (125 mg in
100 ml PBS) beginning at the time of oxygen exposure signifi-
cantly blunted the oxygen-induced augmentation of lung injury
on Day 3 after LPS (Figure 4). We assessed the effects of CGS-
21680 on Day 3, when an oxygen-mediated increase in lung
injury was most pronounced in WT mice (7). A marked decrease
in histologic injury was evident (Figure 4A), as well as a decrease
in BAL protein (Figure 4B), and the total alveolar cell count,
including both neutrophils and macrophages (Figure 4C). CGS-
21680 did not exert a significant effect in LPS-exposed WT mice,
or in LPS plus oxygen–exposed ADORA2A2/2 mice. The amount
of BALMIP-2 was lower in LPS plus oxygen–exposed WT mice
treated with CGS-21680 (Figure 4D), but CGS-21680 did not
alter BAL KC secretion (not shown).
We isolated BAL cells to determine the importance of
ADORA2A pathway activation in macrophage phenotype. Add-
ing oxygen to LPS decreased the overall percentage of macro-
phages (F4-801) on Day 3, an effect that was reversed with the
addition of CGS-21680 (Table 2). The addition of CGS-21680
also decreased CD11b1 expression among F4-801 macrophages
(Figure E2A). Furthermore, CGS-21680 induced a significant
Figure 4. CGS-21680 hydrochloride, an
ADORA2A-specific agonist, abrogates
lung injury in WT mice induced by
LPS plus oxygen. To do so, CGS-
21680 prevents the oxygen-mediated
suppression of the ADORA2A pathway.
Statistics were determined by compar-
ing groups with and without CGS-
21680 treatment. (A) Representative
low-power (34) and high-power (inset,
340) hematoxylin and eosin–stained
lung sections on Day 3 after intratracheal
(IT) LPS demonstrate a CGS-21680–
mediated reduction in histologic injury
in WT mice exposed to LPS plus oxygen.
(B) BAL protein is significantly reduced
with the addition of CGS-21680 to WT
mice exposed to LPS plus oxygen *Signif-
icant compared with the WT L 1 O2
group. No measureable CGS-21680–
mediated difference was evident inWTmice
exposed to LPS alone, or in ADORA2A2/2
mice exposed to LPS plus oxygen. (C)
Adding CGS-21680 to LPS plus oxygen–
exposed WT mice significantly reduced
total BAL cells as well as BAL neutrophils
and macrophages. *Significant com-
pared with the WT L 1 O2 group. (D)
CGS-21680 blunted the LPS plus oxy-
gen–mediated increase in BAL MIP-2.
*Significant compared with the WT L 1
O2 group. (E) We isolated naive, WT al-
veolar macrophages (Mf) and exposed
them in culture to LPS, oxygen, or both
in combination for 24 hours. Statistics were
determined by comparing all groups at the
same time point. Adding CGS-21680 to
the LPS plus oxygen–exposed macro-
phages significantly blunted the 24-hour
TNF-a and MIP-2 secretion. *Significant
compared with the media (M) and M 1
O2 groups. ^Significant compared with the
LPS and L1 O2 1 CGS-21680 groups, with
no significant difference between the LPS
and L 1 O2 1 CGS-21680 groups (n ¼
5–6 in each group).
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reduction in surface expression of cosignaling molecules CD86
and CD40 (Table 2 and Figure E2C) among F4-801 CD11b1
cells from LPS plus oxygen–exposed mice. In isolated naive al-
veolar macrophages stimulated for 24 hours, adding CGS-21680
to LPS plus oxygen–treated cells significantly reduced TNF-a and
MIP-2 concentrations, compared with sham treatment in the LPS
plus oxygen group (Figure 4E). Therefore, CGS-21680, a specific
ADORA2A agonist, significantly reduced the expression of
proinflammatory markers in macrophages from WT mice ex-
posed to LPS plus oxygen.
In WT mice, adding 60% oxygen to LPS decreased lung
ADORA2A mRNA on Days 2 and 3 after IT LPS (Figure 5A).
We also wanted to assess the effects of oxygen on ADORA2B in
response to oxygen-mediated effects on ADORA2A. However, no
differences in lung ADORA2B mRNA were evident between WT
or ADORA2A2/2 mice exposed to LPS and oxygen for 2 or 3 days
(Figure E2D). To determine whether oxygen may specifically de-
crease macrophage ADORA2A, we used both a macrophage cell
line (MH-S) and ex vivo alveolar and peritoneal macrophages. LPS
induced a 3- to 4-fold increase in ADORA2A mRNA in MH-S
cells at 8 hours, and this increase was sustained at 24 hours (Figure
5B). Adding oxygen to LPS-treated macrophages significantly de-
creased ADORA2A mRNA compared with LPS alone, as we
observed in lung tissue. Adding oxygen to media-treated MH-S
cells did not alter ADORA2A mRNA concentrations. To deter-
mine whether an oxygen-induced decrease in ADORA2A mRNA
translated to a functional effect on the macrophage ADORA2A
pathway, we measured intracellular cAMP. ADORA2A activation
increases cAMP, and receptor-specific manipulation alters cAMP
concentrations (33). LPS significantly increased cAMP in MH-S
cells (Figure 5C). Exposing LPS-stimulated macrophages to supple-
mental oxygen significantly reduced cAMP compared with LPS
treatment alone, an effect that was negated by pretreatment with
the ADORA2A agonist CGS-21680. Adding supplemental oxygen
to media-exposed macrophages did not alter cAMP concentrations,
and CGS-21680 exerted no effect. To assess the impact of the
manipulation of ADORA2A signaling on macrophage phenotype
and function, we measured cytokines (TNF-a and MCP-1) and
cosignaling molecules (CD86 and CD40) in macrophages by flow
cytometry. When added to LPS-exposed peritoneal macrophages,
60% oxygen significantly increased TNF-a and MCP-1 at 24 hours,
an effect blocked by pretreatment with CGS-21680 (Figure 5D).
CGS-21680 also reduced the abundance of cosignaling molecules
CD86 and CD40 in LPS plus oxygen–treated macrophages (Figure
5E). Adding supplemental oxygen to media-exposed peritoneal
macrophages did not increase TNF-a, MCP-1, CD86, or CD40
after 24 hours. When we pretreated macrophages with a nonspecific
adenosine receptor agonist, NECA (3 mM), no additional reduction
was observed in cytokines or cosignaling molecule expression com-
pared with CGS-21680 treatment, indicating a primary role for
ADORA2A signaling in our model (data not shown).
NF-kB mediates the expression of several proinflammatory
molecules, including TNF-a andMIP-2 (34, 35), and may regulate
the expression of cosignaling molecules CD86 and CD40 (36). We
previously observed an LPS plus oxygen–mediated increase in
macrophage NF-kB p65 activity in comparison to LPS exposure
alone. Oxygen alone exerted no effect on cells exposed to media
(7). In alveolar macrophages exposed to LPS, NF-kB blockade
with SN-50 (50 mg/ml) mildly reduced TNF-a, but exerted no
effect on MIP-2 (Figure 5F). In alveolar macrophages exposed
to LPS plus oxygen, NF-kB blockade using SN-50 administered
at the time of oxygen exposure led to a significant, greater than
50% reduction in alveolar macrophage TNF-a and MIP-2 pro-
duction. In peritoneal macrophages, the addition of oxygen to
LPS increased p65 activity by 50% compared with LPS alone.
Pretreatment with CGS-21680 in the group with LPS plus oxygen
reduced total NF-kB p65 activity by greater than 50% of the
amount induced by oxygen plus LPS. CGS-21680 exerted no ef-
fect on cells exposed to LPS alone (Figure 5G).
Both Myeloid and Nonmyeloid ADORA2A Modulate LPS plus
Oxygen–Induced Lung Injury
To determine the specific contribution of inflammatory-cell
ADORA2A in modulating lung injury, we performed chimera
experiments by irradiating mice and transferring bone marrow–
derived cells to designated groups. We used CD45.1 (WT) mice to
differentiate leukocytes from the CD45.2 leukocyte common an-
tigen found in ADORA2A2/2 mice, allowing us to distinguish
donor from recipient cells. Eight weeks after bone marrow cell
transfer, we determined chimerism to be greater than 90% in
all groups of mice (flow cytometry; data not shown). We exposed
irradiated and nonirradiated age-matchedWT and ADORA2A2/2
mice to LPS plus oxygen, and assessed the response in groups of
chimeras. After 2 days of LPS plus oxygen (the earliest time point
when ADORA2A2/2 mice first demonstrate an appreciable aug-
mentation of lung injury compared with WT mice), injury param-
eters were evaluated (Figure 6). Histologic injury (Figure 6A) was
most severe in ADORA2A2/2 mice that received ADORA2A2/2
myeloid cells. WT mice that received ADORA2A2/2 myeloid
cells demonstrated the second most severe histologic injury. His-
tologic injury was significantly milder in ADORA2A2/2 mice that
received WT myeloid cells and in WT mice that received WT
myeloid cells. The concentration of BAL protein (Figure 6B)
was higher in both chimera groups that received ADORA2A2/2
myeloid cells, compared with both groups that received WT my-
eloid cells. BAL total cells (Figure 6C) were significantly increased
only in ADORA2A2/2 mice that received ADORA2A2/2 cells,
compared with WT mice that received WT cells. BAL neutrophils
(Figure 6D) were significantly increased only in both chimera
groups that received ADORA2A2/2 myeloid cells. Although
BAL macrophage numbers were no different between treatment
groups (Figure 6D), both F4-801 CD11c1 and F4-801 CD11b1
macrophages from WT mice that received ADORA2A2/2 mye-
loid cells expressed significantly more TNF-a than did macro-
phages from both chimera groups that received WT myeloid
cells (Figure 6E).




Day 3 Exposure Percent F4-801 Percent CD11b1 CD86 MFI CD40 MFI
WT LPS (L) 18 (3.8)* 25 (4.1) 72 (22.9)† 74 (11.5)
WT L 1 O2 7 (3.5) 30 (2.1) 147 (20.4) 85 (19.2)
WT L 1 O2 1 CGS 24 (0.8)* 10 (0.5)
‡ 59 (13.6)† 25 (3.6)x




7 (1.1) 36 (2.6) 240 (10.8)¶ 92 (7.5)
Definition of abbreviations: ADORA2A, anti-inflammatory A2A adenosinergic recep-
tor; A2AR2/2, ADORA2A-deficient; BAL, bronchoalveolar lavage; CGS, CGS-21680
hydrochloride; L, lipopolysaccharide; MFI, mean fluorescence intensity; WT, wild-type.
Day 3 BAL exudative macrophages (F4-801 CD11b1) from WT mice treated
with the ADORA2A agonist CGS-21680 expressed significantly less of the M1
inflammatory markers CD86 and CD40 according to flow cytometry analysis.
Statistics were determined by comparing all groups with one-way ANOVA. Val-
ues are listed as averages (SEMs) (n ¼ 4–6 in each group).
* In the Percent F4-801 column, significant compared with the WT L 1 O2,
ADORA2A2/2 L 1 O2, and ADORA2A
2/2 L 1 O2 1 CGS-21680 groups.
y Significant compared with the WT L 1 O2 group.
z Significant compared with all other groups, among F4-801 CD11b1 inflam-
matory macrophages.
x Significant compared with all groups.
¶ In the CD86 MFI column, significant compared with all other groups.
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DISCUSSION
Weconclude thatmacrophageADORA2A is a critical modifier of
the oxygen-induced augmentation of inflammation and lung injury
after intratracheal LPS. In the absence of ADORA2A, mice ex-
posed to LPS plus oxygen exhibit more severe lung injury, and
alveolarmacrophages from thesemice demonstrate an augmented
and sustained proinflammatoryM1-phenotype, known to be asso-
ciated with poor outcomes (21, 22). Furthermore, supplemental
oxygen delivery after LPS augments the macrophage proinflam-
matory state even in WT mice, at least in part by attenuating the
LPS-induced increase in anti-inflammatory ADORA2A expres-
sion. Delivery of the ADORA2A-specific agonist CGS-21680
increased ADORA2A signaling, to reduce lung injury signifi-
cantly and dampen the macrophage proinflammatory state in
WT mice exposed to LPS and oxygen.
The importance of the macrophage inflammatory state in an-
imal models of lung injury has been increasingly recognized (10,
30, 31). Because of the great overlap in surface marker expres-
sion between different macrophage inflammatory subpopula-
tions (21), we and others have sought to generate expanded
marker sets to define macrophage subpopulations further. In
our LPS plus oxygen lung-injury model, alveolar macrophages
initiate and propagate lung inflammation, attributable in large
part to an enhanced recruitment of neutrophils to the alveolar
Figure 5. Oxygen blunts the induc-
tion by LPS of ADORA2A and
ADORA2A pathway components in
macrophages to augment the proin-
flammatory profile. This effect is ne-
gated by the ADORA2A agonist,
CGS-21680. Statistics were deter-
mined by comparing all groups at
the same time point. (A) Adding ox-
ygen to LPS reduced lung ADORA2A
mRNA concentrations on Days 2
and 3. *Significant compared with
LPS-treated mice at the same time
point. FC, fold change. (B) LPS
induced an early and sustained in-
crease in ADORA2A mRNA in mu-
rine alveolar macrophage cell line
(MH-S) cells, an effect negated by
the addition of oxygen. *Significant
compared with the media and M 1
O2 groups. ^Significant compared
with the L 1 O2 8-hour and L 1
O2 24-hour groups. (C) Oxygen sig-
nificantly reduced the LPS-mediated
increase in intracellular cyclic adeno-
sine monophosphate (IC cAMP), an
effect negated by treatment with
CGS-21680. *Significant compared
with the LPS 1 O2 1 CGS-21680
group. n.s., between the LPS and
LPS 1 CGS-21680 groups. (D) Add-
ing CGS-21680 to LPS plus oxygen–
treated cells significantly reduced IC
TNF-a and IC MCP-1 production to
concentrations comparable to those
with LPS treatment alone. *Signifi-
cant compared with the L 1 O2
group. (E) Adding CGS-21680 to
LPS plus oxygen–treated cells signif-
icantly reduced the CD86 and CD40
mean fluorescence intensity (MFI)
compared with LPS treatment alone.
*Significant compared with the L 1
O2 group. (F) Adding the NF-kB
inhibitor, cell permeable synthetic
peptide (SN-50) (50 mg/ml), at
the time of oxygen exposure (3
hours after LPS) most significantly
reduced the macrophage secre-
tion of TNF-a and MIP-2 in LPS
plus oxygen–exposed cells at 24 hours. *Significant compared with the LPS 1 SN-50 group. ^Significant compared with all other groups for each
cytokine. A small reduction in TNF-a secretion by LPS-treated cells was evident when SN-50 was added, but with no significant change in MIP-2. (G)
LPS plus oxygen exposure significantly increased NF-kB activity in macrophages compared with LPS alone. Adding CGS-21680 to the LPS plus
oxygen–treated group led to a 50% reduction in the increase in NF-kB activity observed with the addition of oxygen to LPS versus LPS alone.
*Significant compared with the L1 O2 group, with n.s. between the L1 O2 1 CGS-21680 and LPS or LPS1 CGS-21680 groups (n¼ 5–6 in each group).
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space. In ADORA2A-deficient mice, the alveolar recruitment of
neutrophils is further enhanced after LPS plus oxygen exposure
because of increased chemokine secretion, predominantly from
macrophages. Alveolar macrophages from ADORA2A2/2 mice
exposed to LPS plus oxygen exhibit an increased production of
MCP-1, a potent monocyte chemoattractant, indicating that
macrophages fromADORA2A2/2 mice promote both monocyte
and neutrophil recruitment to the alveolar space.
Although we observed that moderate concentrations of oxy-
gen augmented mild lung inflammation by reducing ADORA2A
abundance or signaling through ADORA2A, the mechanisms
responsible for this effect remain unknown. Oxygen blunted
Aggarwal, D’Alessio, Eto, et al.: Oxygen Augments Experimental Models of Lung Injury 643
 
the LPS-mediated increase in ADORA2A mRNA. The tran-
scription factor hypoxia-inducible factor–1 (HIF-1) is increased
after LPS and stabilized under hypoxic conditions, and is known
to induce the transcription of ADORA2A (37, 38). The degra-
dation of HIF-1 requires the activity of prolyl hydroxylases
(PHDs), which use oxygen as a substrate with a Michaelis-
Menten constant known to demonstrate peak activity at 45%
oxygen (39). One possibility, as Chandel and Budinger pro-
posed, involves supranormal oxygen (60%) maximizing PHD
activity in excess of that which is present in ambient air (21%)
(40). If this is the case, then macrophages exposed to oxygen after
LPS in our model would manifest relatively lower HIF-1 concen-
trations compared with macrophages exposed to LPS alone,
which could decrease ADORA2A mRNA.
Adding 60%oxygen also decreased the LPS-induced increase
in macrophage cAMP, indicative of functional ADORA2A
pathway blockade. This may result from reduced ADORA2A
total protein or reduced ADORA2A surface receptor protein.
Collins and colleagues recently showed that hyaluronic acid
(HA) prevented the cycling of ADORA2A to the cell mem-
brane, but exerted no effect on total ADORA2A protein con-
centrations (29). The mechanisms by which oxygen alters
ADORA2A signaling after LPS exposure remain unknown,
but possibilities include the production of reactive oxygen spe-
cies (41), direct binding to a cell surface receptor/coreceptor, or
indirect interaction through HA/Toll-like receptor (TLR) sig-
naling pathways (42–44).
ADORA2A is an important regulator of inflammation in other
models of injury, yet the actions of ADORA2A in macrophages re-
main largely unknown (25, 29, 45–48). Because CGS-21680 does
express weak affinity for another adenosine receptor, ADORA2B
(1/100 potency compared with ADORA2A), we used NECA as
a nonselective AR agonist to assess the potential additional contri-
bution of ADORA2B to the observed response in our model (11).
We observed no additional anti-inflammatory benefit of NECA
over CGS-21680, reinforcing the principal role of ADORA2A.
The inhibitory effect of ADORA2A in macrophages has been
identified in models of inflammation involving signaling through
several TLRs, including 2, 3, 7, and 9 (49). Therefore, ADORA2A
binding likely inhibits a common proinflammatory activator (11,
26). Multiple mechanisms surely exist, but fundamental to the anti-
inflammatory effects of the ADORA2A pathway is its inhibition
of the transcription factor NF-kB (50, 51). CGS-21680, a specific
ADORA2A agonist, blocked 50% of the oxygen-induced increase
in NF-kB activity in macrophages exposed to LPS. However, as
others have observed with adenosine (52), CGS-21680 exerted no
effect on NF-kB activity in macrophages exposed to LPS alone,
suggesting distinct oxygen-mediated effects on NF-kB compared
with LPS. One possibility involves a differential effect on interleukin-
1 receptor-associated kinase M, a known repressor of NK-kB sig-
naling that directly associates with CD86 according to coimmuno-
precipitation experiments (53). CD86 expression in macrophages
was also down-regulated with CGS-21680 treatment.
Macrophages from ADORA2A2/2 mice may promote inflam-
mation by interactions with other cell types, including neutrophils
and epithelial cells. Others have shown that the neutrophil acti-
vation of macrophages occurs via CD86 (36, 48). When we sys-
temically depleted neutrophils, the expression of CD86 in F4-801
CD11b1 alveolar macrophages was reduced, suggesting a possible
neutrophil-mediated effect on macrophage CD86 expression (Fig-
ure E1C). In isolated macrophages, the antibody-mediated block-
ade of CD86 did not alter the abundance of other cosignaling
molecules or intracellular cytokines in the context of LPS, oxygen,
or the two in combination (data not shown). However, we did not
test this effect in the presence of neutrophils.
Epithelial ADORA2A has been shown to modify lung water ac-
cumulation (54, 55) and prevent allograft airway rejection (49, 56).
Our chimera experiments demonstrated that the absence of either
myeloid or epithelial/endothelial ADORA2A augments lung injury
after LPS plus oxygen exposure, and the absence of both exerts an
additive effect on lung injury. In contrast to our findings, Reutershan
and colleagues concluded that epithelial or endothelial ADORA2A
may be proinflammatory (25). The harmful effect of lacking epithe-
lial ADORA2A may be particularly revealing in our lung injury
model, in which lung epithelial cells are constantly exposed to ele-
vated oxygen tensions. Therefore, the addition of supplemental ox-
ygen may constitute a pertinent difference in our model. Adding
60% oxygen to LPS-treated alveolar epithelial cells (murine lung
epithelial-12 cell line) in contact with macrophages synergistically
increased the secretion of neutrophil-recruiting chemokines, and
subsequently enhanced neutrophil migration (unpublished observa-
tions by Neil R. Aggarwal and Landon S. King). In the absence of
epithelial ADORA2A, the synergistic proinflammatory effect
of this cell–cell interaction may be even more pronounced.
Macrophage ADORA2A prevents the augmentation of lung
injury after LPS and oxygen. Without ADORA2A, macrophages
exposed to LPS plus oxygen displayed both an increased and sus-
tained proinflammatory M1 phenotype, leading to an enhanced
recruitment of alveolar neutrophils and the augmentation of lung
injury. In WT mice, supplemental oxygen appears to blunt LPS-
induced increases in cAMP, consistent with an ADORA2A path-
way blockade. The effects of oxygen in macrophages are clearly
multifactorial. Our experiments demonstrate that supplemental
oxygen, as a modifiable exposure, augments lung inflammation
through the down-regulation of the ADORA2A pathway. Al-
though we do not understand the specific oxygen-induced effects
;
Figure 6. Chimera experiments demonstrate protective effects of myeloid and nonmyeloid ADORA2A in the LPS plus oxygen lung-injury model.
Statistics were determined by comparing all groups at the same time point. All mice were exposed to LPS plus oxygen for 2 days. (A) Representative
low-power (34) and high-power (inset, 340) hematoxylin and eosin–stained lung sections on Day 2 after delivery of IT LPS plus oxygen to defined
chimera groups demonstrate increased alveolar consolidation in mice with ADORA2A2/2 myeloid cells. Quantitative assessment, based on a lung-
injury scoring system, demonstrated maximal histologic injury in ADORA2A2/2 mice that received ADORA2A2/2 myeloid cells, with the next most
severe injury in the WT mice that received ADORA2A2/2 myeloid cells, compared with other groups. *Significant increase in lung injury compared
with the WT mice 1 WT cell group. ^Significant increase compared with the ADORA2A2/2 mice 1 WT cell group. #Significant increase compared
with all three groups. (B) Concentrations of BAL protein were significantly higher in WT and ADORA2A2/2 mice that received ADORA2A2/2 myeloid
cells. *Significant compared with the WT mice 1 WT cell group. ^Significant compared with the ADORA2A2/2 mice 1 WT cell group. (C) BAL total
cell count was significantly increased in ADORA2A2/2 mice that received ADORA2A2/2 cells. *Significant only compared with the WT mice 1 WT
cell and the ADORA2A2/2 mice 1 WT cell groups. (D) BAL neutrophils were significantly increased in both groups that received ADORA2A2/2
myeloid cells when assessed on Day 2. *Significant compared with the WT mice 1 WT cell group. ^Significant compared with the ADORA2A2/2
mice 1 WT cell group. (E) Among ex vivo alveolar macrophages (F4-801 CD11c1 and F4-801 CD11b1), we observed a significant increase in IC
TNF-a production when assessed by flow cytometry. *Significant compared with the WT mice 1 WT cell group. ^Significant compared with the
ADORA2A2/2 mice 1 WT cell group (n ¼ 4 in each group). BM, bone marrow.
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in humans with acute lung inflammation and injury, the protective
effects of the ADORA2A agonist CGS-21680 on the oxygen-
mediated augmentation of LPS-induced murine lung injury
may provide an avenue for investigation in human trials ofARDS.
Author disclosures are available with the text of this article at www.atsjournals.org.
References
1. Matthay M, Zimmerman G. Acute lung injury and the acute respiratory
distress syndrome: four decades of inquiry into pathogenesis and ra-
tional management. Am J Respir Cell Mol Biol 2005;33:319–327.
2. Gajic O, Dabbagh O, Park PK, Adesanya A, Chang SY, Hou P, Anderson
H, Hoth JJ, Mikkelsen ME, Gentile NT, et al. Early identification of
patients at risk of acute lung injury: evaluation of lung injury prediction
score in a multicenter cohort study. Am J Respir Crit Care Med 2011;
183:462–470.
3. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung
injury. Am J Physiol Lung Cell Mol Physiol 2008;295:L379–L399.
4. Bertolini G, Lewandowski K, Bion J, Romand JA, Villar J, Thorsteinsson A,
Damas P, Armaganidis A, Lemaire F, Minelli C, et al. Epidemiology and
outcome of acute lung injury in European intensive care units. Intensive
Care Med 2004;30:51–61.
5. Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ. Clinical pre-
dictors of the adult respiratory distress syndrome. Am J Surg 1982;
144:124–130.
6. Rachmale S, Li G, Gregory W, Malinchoc M, Gajic O. Practice of ex-
cessive inspired oxygen supplementation and effect on pulmonary
outcomes in mechanically ventilated patients with acute lung injury.
Respir Care 2012;57:1887–1893.
7. Aggarwal NR, D’Alessio FR, Tsushima K, Files DC, Damarla M,
Sidhaye VK, Fraig MM, Polotsky VY, King LS. Moderate oxygen
augments lipopolysaccharide-induced lung injury in mice. Am J
Physiol Lung Cell Mol Physiol 2010;298:371–381.
8. Thiel M, Chouker A, Ohta A, Jackson E, Caldwell C, Smith P, Lukashev
D, Bittmann I, Sitkovsky MV. Oxygenation inhibits the physiological
tissue-protecting mechanism and thereby exacerbates acute inflam-
matory lung injury. PLoS Biol 2005;3:e174.
9. Sue RD, Belperio JA, Burdick MD, Murray LA, Xue YY, Dy MC,
Kwon JJ, Keane MP, Strieter RM. CXCR2 is critical to hyperoxia-
induced lung injury. J Immunol 2004;172:3860–3868.
10. Janssen WJ, Barthel L, Muldrow A, Oberley-Deegan RE, Kearns MT,
Jakubzick C, Henson PM. Fas determines differential fates of resident
and recruited macrophages during resolution of acute lung injury. Am
J Respir Crit Care Med 2011;184:547–560.
11. Haskó G, Pacher P, Deitch E, Vizi ES. Shaping of monocyte and macro-
phage function by adenosine receptors. Pharmacol Ther 2007;113:264–275.
12. Nathan C. Points of control in inflammation. Nature 2002;420:8946–8952.
13. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat
Rev Immunol 2005;5:953–964.
14. Gordon S, Martinez FO. Alternative activation of macrophages: mech-
anism and functions. Immunity 2010;32:593–604.
15. Maus UA, Janzen S, Wall G, Srivastava M, Blackwell TS, Christman JW,
Seeger W, Welte T, Lohmeyer J. Resident alveolar macrophages are
replaced by recruited monocytes in response to endotoxin-induced
lung inflammation. Am J Respir Cell Mol Biol 2006;35:227–235.
16. Maus UA, Koay MA, Delbeck T, Mack M, Ermert M, Ermert L,
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